{"altmetric_id":508755,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["VEGFRSSfeeds"],"posts_count":1}},"citation":{"abstract":"The Cancer and Leukemia Group B (CALGB) conducted a multi-center phase II trial to evaluate the efficacy and safety of vatalanib in previously untreated patients with malignant mesothelioma and to evaluate potential biomarkers of disease response (CALGB 30107).","abstract_source":"pubmed","altmetric_jid":"4f6fa4fe3cf058f610003039","authors":["Jahan T","Gu L","Kratzke R","Dudek A","Otterson GA","Wang X","Green M","Vokes EE","Kindler HL","Thierry Jahan","Lin Gu","Robert Kratzke","Arkadiusz Dudek","Gregory A. Otterson","Xiaofei Wang","Mark Green","Everett E. Vokes","Hedy Lee Kindler"],"doi":"10.1016\/j.lungcan.2011.11.014","endpage":"396","first_seen_on":"2011-12-27T14:43:50+00:00","funders":["nci"],"issns":["1872-8332","0169-5002","01695002"],"issue":"3","journal":"Lung Cancer (01695002)","last_mentioned_on":1324996490,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22197613?dopt=Abstract"],"pmid":"22197613","pubdate":"2011-12-22T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"393","subjects":["neoplasms"],"title":"Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107).","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500211005885","volume":"76","mendeley_url":"http:\/\/www.mendeley.com\/research\/vatalanib-malignant-mesothelioma-phase-ii-trial-cancer-leukemia-group-b-calgb-30107"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4782626,"mean":5.7258040009438,"rank":4004472,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":4782626,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":237195,"mean":4.41015429564,"rank":193657,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":237195,"percentile":1},"this_journal":{"total_number_of_other_articles":503,"mean":2.7633545816733,"rank":413,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":503,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":0.96923076923077,"rank":12,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":14,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1},"by_discipline":{"Medicine and Dentistry":1,"Agricultural and Biological Sciences":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/VEGFRSSfeeds\/status\/151672388982026241","citation_ids":[508755],"posted_on":"2011-12-27T14:34:50+00:00","author":{"name":"VEGF RSS Feeds","image":"https:\/\/pbs.twimg.com\/profile_images\/516588600\/VEGF_normal.jpg","id_on_source":"VEGFRSSfeeds","tweeter_id":"88511740","geo":{"lt":null,"ln":null},"followers":363},"tweet_id":"151672388982026241"}]}}